Xin Huang

Director of Finance/CFO at PharmaLegacy Laboratories (Shanghai) Co., Ltd.

42 year

Commercial Services

Consumer Services

Profile

Xin Huang is currently working as the Financial Director, Director & Deputy GM at PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Mr. Huang's education includes an MBA from Indiana University.

Xin Huang active positions

Companies	Position	Start
PharmaLegacy Laboratories (Shanghai) Co., Ltd. PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.	Director of Finance/CFO	2022-01-31

All active positions of Xin Huang

Training of Xin Huang

Indiana University

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Xin Huang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
PharmaLegacy Laboratories (Shanghai) Co., Ltd. PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.	Commercial Services